Mitoxantrone in progressive multiple sclerosis: a placebo-controlled, double-blind, randomised, multicentre trial
Top Cited Papers
- 1 December 2002
- journal article
- clinical trial
- Published by Elsevier BV in The Lancet
- Vol. 360 (9350), 2018-2025
- https://doi.org/10.1016/s0140-6736(02)12023-x
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- Defining the clinical course of multiple sclerosisNeurology, 1996
- Noninvasive Assessment of Mitoxantrone Cardiotoxicity in Relapsing Remitting Multiple SclerosisThe Journal of Clinical Pharmacology, 1995
- The health assessment questionnaire 1992. Status and reviewArthritis & Rheumatism, 1992
- Suppression of demyelination by mitoxantroneInternational Journal of Immunopharmacology, 1991
- The Canadian cooperative trial of cyclophosphamide and plasma exchange in progressive multiple sclerosisThe Lancet, 1991
- Suppression of acute and relapsing experimental allergic encephalomyelitis with mitoxantroneClinical Immunology and Immunopathology, 1987
- Suppression of experimental allergic encephalomyelitis by mitoxantroneClinical Immunology and Immunopathology, 1985
- Two-Sample Asymptotically Distribution-Free Tests for Incomplete Multivariate ObservationsJournal of the American Statistical Association, 1984
- Rating neurologic impairment in multiple sclerosisNeurology, 1983
- Intensive Immunosuppression in Progressive Multiple SclerosisNew England Journal of Medicine, 1983